v3.20.1

Operating costs | 12 Months Ended
--- | ---
Dec. 31, 2019
Operating costs |
Operating costs | 7. Operating costs Operating result has been calculated after charging (-) / crediting: RESEARCH AND DEVELOPMENT EXPENDITURE The following table summarizes research and development expenditure for the years ended December 31, 2019, 2018 and 2017.
|  | Year ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  |  | (Euro, in thousands)
Personnel costs |  | € | (124,260) |  | € | (81,352) |  | € | (59,950)
Subcontracting |  |  | (249,926) |  |  | (197,644) |  |  | (123,054)
Disposables and lab fees and premises costs |  |  | (23,880) |  |  | (25,525) |  |  | (22,277)
Depreciation |  |  | (10,874) |  |  | (5,655) |  |  | (3,679)
Other operating expenses |  |  | (18,380) |  |  | (12,699) |  |  | (9,542)
Total R&D expenses |  | € | (427,320) |  | € | (322,875) |  | € | (218,502)
All research and development expenditures are tracked against detailed budgets and allocated by individual project. The table below summarizes our research and development expenditure for the years ended December 31, 2019, 2018 and 2017, broken down by program.
|  | Year ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  |  | (Euro, in thousands)
Filgotinib program |  | € | (100,032) |  | € | (66,138) |  | € | (53,212)
IPF program on GLPG1690 |  |  | (75,951) |  |  | (72,718) |  |  | (16,190)
OA program on GLPG1972 |  |  | (19,958) |  |  | (15,751) |  |  | (7,317)
Toledo program |  |  | (47,204) |  |  | (20,967) |  |  | (8,075)
CF program |  |  | (3,897) |  |  | (30,137) |  |  | (46,192)
AtD program on MOR106 |  |  | (24,051) |  |  | (14,999) |  |  | (8,404)
Other programs |  |  | (156,227) |  |  | (102,165) |  |  | (79,113)
Total R&D expenses |  | € | (427,320) |  | € | (322,875) |  | € | (218,502)
GENERAL AND ADMINISTRATIVE EXPENSES The following table summarizes the general and administrative expenses for the years ended December 31, 2019, 2018 and 2017.
|  | Year ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  |  | (Euro, in thousands)
Personnel costs and directors fees |  | € | (51,906) |  | € | (25,495) |  | € | (17,756)
Depreciation |  |  | (1,513) |  |  | (513) |  |  | (606)
Legal and professional fees |  |  | (11,775) |  |  | (4,284) |  |  | (2,427)
Other operating expenses |  |  | (8,506) |  |  | (5,339) |  |  | (3,626)
Total general and administrative expenses |  | € | (73,701) |  | € | (35,631) |  | € | (24,415)
SALES AND MARKETING EXPENSES The following table summarizes the sales and marketing expenses for the years ended December 31, 2019, 2018 and 2017.
|  | Year ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  |  | (Euro, in thousands)
Personnel costs |  | € | (7,558) |  | € | (2,282) |  | € | (2,156)
Depreciation |  |  | (61) |  |  | — |  |  | —
External outsourcing costs |  |  | (15,722) |  |  | (1,284) |  |  | (42)
Other operating expenses |  |  | (1,236) |  |  | (580) |  |  | (604)
Total sales and marketing expenses |  | € | (24,577) |  | € | (4,146) |  | € | (2,803)

X
- Definition The entire disclosure for operating costs. + References No definition available. + Details
Name: | glpg_DisclosureOfOperatingCostsExplanatoryTextBlock
Namespace Prefix: | glpg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_ExpenseByNatureAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration